Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 92.38 USD -0.27%
Market Cap: 115B USD
Have any thoughts about
Gilead Sciences Inc?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Income Statement

28.3B
+2%
Revenue
Growth Rates:
1 Year
+3%
3 Years
+3%
5 Years
+27%
7 Years
+3%
10 Years
+37%
10.9B
+5%
Operating Income
Growth Rates:
1 Year
+7%
3 Years
-9%
5 Years
+150%
7 Years
-32%
10 Years
-10%
126m
-88%
Net Income
Growth Rates:
1 Year
-98%
3 Years
-98%
5 Years
-95%
7 Years
-99%
10 Years
-99%

Earnings Waterfall
Gilead Sciences Inc

Revenue
28.3B USD
Cost of Revenue
-6.3B USD
Gross Profit
22B USD
Operating Expenses
-11.2B USD
Operating Income
10.9B USD
Other Expenses
-10.7B USD
Net Income
126m USD

Income Statement
Gilead Sciences Inc

Rotate your device to view
Income Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
20 696
N/A
24 890
+20%
27 485
+10%
29 194
+6%
31 447
+8%
32 639
+4%
32 839
+1%
32 371
-1%
31 576
-2%
30 390
-4%
29 101
-4%
28 466
-2%
27 478
-3%
26 107
-5%
24 690
-5%
23 197
-6%
22 281
-4%
22 127
-1%
22 320
+1%
22 357
+0%
22 365
+0%
22 449
+0%
22 716
+1%
22 174
-2%
23 147
+4%
24 689
+7%
25 564
+4%
26 638
+4%
27 482
+3%
27 305
-1%
27 472
+1%
27 515
+0%
27 136
-1%
27 281
+1%
27 043
-1%
27 382
+1%
27 391
+0%
27 116
-1%
27 450
+1%
27 805
+1%
28 299
+2%
Gross Profit
Cost of Revenue
(3 583)
(3 788)
(3 857)
(3 930)
(4 007)
(4 006)
(4 317)
(4 183)
(4 248)
(4 261)
(4 025)
(4 287)
(4 190)
(4 371)
(4 415)
(4 485)
(4 539)
(4 853)
(4 809)
(4 613)
(4 562)
(4 675)
(4 687)
(4 751)
(4 857)
(4 572)
(4 964)
(5 290)
(5 372)
(6 601)
(6 664)
(6 716)
(6 888)
(5 657)
(5 634)
(5 634)
(5 804)
(6 019)
(6 170)
(6 272)
(6 281)
Gross Profit
17 113
N/A
21 102
+23%
23 628
+12%
25 264
+7%
27 440
+9%
28 633
+4%
28 522
0%
28 188
-1%
27 328
-3%
26 129
-4%
25 076
-4%
24 179
-4%
23 288
-4%
21 736
-7%
20 275
-7%
18 712
-8%
17 742
-5%
17 274
-3%
17 511
+1%
17 744
+1%
17 803
+0%
17 774
0%
18 029
+1%
17 423
-3%
18 290
+5%
20 117
+10%
20 600
+2%
21 348
+4%
22 110
+4%
20 704
-6%
20 808
+1%
20 799
0%
20 248
-3%
21 624
+7%
21 409
-1%
21 748
+2%
21 587
-1%
21 097
-2%
21 280
+1%
21 533
+1%
22 018
+2%
Operating Income
Operating Expenses
(4 981)
(5 720)
(6 035)
(6 467)
(6 538)
(6 444)
(7 049)
(7 793)
(8 119)
(7 664)
(8 327)
(7 714)
(7 410)
(7 342)
(7 765)
(8 176)
(8 395)
(8 902)
(9 227)
(9 310)
(13 465)
(13 315)
(13 577)
(13 860)
(10 082)
(16 046)
(10 209)
(10 156)
(10 229)
(10 786)
(10 768)
(10 742)
(10 767)
(11 594)
(10 748)
(11 020)
(11 430)
(11 235)
(11 168)
(11 144)
(11 158)
Selling, General & Administrative
(2 620)
(2 983)
(3 080)
(3 278)
(3 236)
(3 426)
(3 466)
(3 544)
(3 472)
(3 398)
(3 563)
(3 570)
(3 618)
(3 830)
(4 025)
(4 108)
(4 177)
(4 056)
(4 089)
(4 204)
(4 308)
(4 381)
(4 427)
(4 571)
(4 625)
(5 151)
(5 119)
(5 231)
(5 315)
(5 246)
(5 274)
(5 280)
(5 303)
(5 673)
(5 503)
(5 470)
(5 572)
(5 537)
(5 514)
(5 559)
(5 649)
Research & Development
(2 361)
(2 737)
(2 955)
(3 189)
(3 302)
(3 018)
(3 583)
(4 249)
(4 647)
(4 266)
(4 764)
(4 144)
(3 792)
(3 512)
(3 740)
(4 068)
(4 218)
(4 846)
(5 138)
(5 106)
(9 157)
(8 934)
(9 150)
(9 289)
(5 457)
(10 895)
(5 090)
(4 925)
(4 914)
(5 540)
(5 494)
(5 462)
(5 464)
(5 921)
(5 246)
(5 551)
(5 859)
(5 698)
(5 655)
(5 586)
(5 510)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
Operating Income
12 132
N/A
15 382
+27%
17 593
+14%
18 797
+7%
20 902
+11%
22 189
+6%
21 473
-3%
20 395
-5%
19 209
-6%
18 465
-4%
16 749
-9%
16 465
-2%
15 878
-4%
14 394
-9%
12 510
-13%
10 536
-16%
9 347
-11%
8 372
-10%
8 284
-1%
8 434
+2%
4 338
-49%
4 459
+3%
4 452
0%
3 563
-20%
8 208
+130%
4 071
-50%
10 391
+155%
11 192
+8%
11 881
+6%
9 918
-17%
10 040
+1%
10 057
+0%
9 481
-6%
10 030
+6%
10 661
+6%
10 728
+1%
10 157
-5%
9 862
-3%
10 112
+3%
10 389
+3%
10 860
+5%
Pre-Tax Income
Interest Income Expense
(355)
(284)
(489)
(561)
(597)
(558)
(881)
(1 036)
(1 189)
(790)
(806)
(712)
(702)
(1 190)
(1 066)
(1 151)
(949)
(964)
(768)
(644)
(715)
227
(210)
(53)
(1 101)
(2 684)
(2 768)
(3 159)
(2 351)
(1 611)
(1 337)
(1 452)
(1 486)
(1 592)
(1 744)
(1 360)
(1 334)
(1 004)
(677)
(1 110)
(948)
Non-Reccuring Items
0
(117)
0
0
0
4
0
0
0
(832)
0
0
0
(270)
0
0
0
(172)
0
0
0
(172)
0
(4 524)
(5 695)
0
(5 832)
(1 404)
(252)
0
(2 815)
(3 049)
(3 478)
(2 700)
(1 823)
(2 254)
(1 897)
(2 257)
(8 534)
(7 832)
(10 038)
Total Other Income
(38)
(125)
42
115
147
24
330
451
594
254
269
175
147
595
501
531
511
563
600
650
652
646
571
444
344
282
139
91
55
(29)
(26)
(8)
25
76
172
237
311
258
172
91
302
Pre-Tax Income
11 739
N/A
14 856
+27%
17 147
+15%
18 350
+7%
20 452
+11%
21 659
+6%
20 922
-3%
19 810
-5%
18 614
-6%
17 097
-8%
16 212
-5%
15 928
-2%
15 323
-4%
13 529
-12%
11 945
-12%
9 916
-17%
8 909
-10%
7 799
-12%
8 116
+4%
8 440
+4%
4 275
-49%
5 160
+21%
4 813
-7%
(570)
N/A
1 756
N/A
1 669
-5%
1 930
+16%
6 720
+248%
9 333
+39%
8 278
-11%
5 862
-29%
5 548
-5%
4 542
-18%
5 814
+28%
7 266
+25%
7 351
+1%
7 237
-2%
6 859
-5%
1 073
-84%
1 538
+43%
176
-89%
Net Income
Tax Provision
(2 355)
(2 797)
(2 978)
(3 335)
(3 569)
(3 553)
(3 581)
(3 469)
(3 540)
(3 609)
(3 592)
(3 736)
(3 744)
(3 393)
(2 969)
(2 200)
(1 806)
(2 335)
(2 223)
(2 481)
(1 583)
204
121
283
(522)
(1 580)
(1 657)
(1 584)
(1 964)
(2 077)
(1 371)
(1 439)
(1 233)
(1 248)
(1 728)
(1 909)
(1 409)
(1 247)
(617)
(506)
(63)
Income from Continuing Operations
9 384
12 059
14 168
15 015
16 883
18 106
17 341
16 341
15 074
13 488
12 620
12 192
11 579
10 136
8 976
7 716
7 103
5 464
5 893
5 959
2 692
5 364
4 934
(287)
1 234
89
273
5 136
7 369
6 201
4 491
4 109
3 309
4 566
5 538
5 442
5 828
5 612
456
1 032
113
Income to Minority Interest
22
42
38
28
29
2
0
5
2
13
17
21
22
(16)
(20)
(26)
(34)
(5)
3
10
15
22
28
30
34
34
28
26
25
24
24
28
25
26
45
42
47
52
26
20
12
Net Income (Common)
9 406
N/A
12 101
+29%
14 207
+17%
15 043
+6%
16 912
+12%
18 108
+7%
17 341
-4%
16 346
-6%
15 076
-8%
13 501
-10%
12 637
-6%
12 213
-3%
11 601
-5%
4 628
-60%
3 464
-25%
2 208
-36%
1 587
-28%
5 455
+244%
5 892
+8%
5 955
+1%
2 693
-55%
5 386
+100%
4 962
-8%
(257)
N/A
1 268
N/A
123
-90%
301
+145%
5 162
+1 615%
7 394
+43%
6 225
-16%
4 515
-27%
4 137
-8%
3 334
-19%
4 592
+38%
5 583
+22%
5 484
-2%
5 875
+7%
5 665
-4%
484
-91%
1 053
+118%
126
-88%
EPS (Diluted)
5.74
N/A
7.35
+28%
9.05
+23%
9.76
+8%
11.25
+15%
11.91
+6%
12.28
+3%
12.06
-2%
11.25
-7%
9.94
-12%
9.57
-4%
9.27
-3%
8.79
-5%
3.5
-60%
2.62
-25%
1.68
-36%
1.21
-28%
4.17
+245%
4.59
+10%
4.66
+2%
2.12
-55%
4.22
+99%
3.89
-8%
-0.2
N/A
1
N/A
0.1
-90%
0.23
+130%
4.08
+1 674%
5.84
+43%
4.93
-16%
3.58
-27%
3.28
-8%
2.65
-19%
3.64
+37%
4.43
+22%
4.35
-2%
4.66
+7%
4.5
-3%
0.38
-92%
0.84
+121%
0.09
-89%

See Also

Summary
GILD intrinsic value, competitors valuation, and company profile.
DCF Valuation
GILD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GILD stock valuation using valuation multiples.
Wall Street Estimates
GILD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GILD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 198,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.